
| Pair Name | Sophocarpine, Oxaliplatin | ||
| Phytochemical Name | Sophocarpine (PubChem CID: 115269 ) | ||
| Anticancer drug Name | Oxaliplatin (PubChem CID: 9887053 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Sophocarpine, Oxaliplatin | |||
| Disease Info | [ICD-11: 2B90.Z] | Colon cancer | Investigative | |
| Biological Phenomena | Inhibition-->Epithelial-mesenchymal transition | |||
| Gene Regulation | Down-regulation | Expression | CDH2 | hsa1000 |
| Down-regulation | Expression | VIM | hsa7431 | |
| Up-regulation | Expression | CDH1 | hsa999 | |
| In Vitro Model | LoVo | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0399 |
| In Vivo Model | Liver metastasis nude mouse models (n = 40) were prepared by the injection of LoVo cells suspended in PBS into the center point of the spleen using a 31-gauge needle. | |||
| Result | Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo | |||
| No. | Title | Href |
|---|---|---|
| 1 | Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol. 2021 Jun;394(6):1263-1274. doi: 10.1007/s00210-020-02032-8. | Click |